Adams Street Partners' Top Holdings: Analysis of RMNI and CRVS
Adams Street Partners Llc's largest positions as of June 30, 2026 are Rimini Street Inc. (RMNI) at 22.68% allocation and Corvus Pharmaceuticals Inc. (CRVS) at 11.06%, highlighting a concentrated portfolio focused on Technology and Healthcare sectors.
As of June 30, 2026, Adams Street Partners Llc, known for its contrarian investment approach focusing on undervalued companies with strong business fundamentals and shareholder-friendly management actions, has built a portfolio heavily concentrated in just two stocks. This analysis delves into the firm's top holdings based on their significant weight within the total portfolio value.
The largest position held by Adams Street Partners is Rimini Street Inc (RMNI), a Technology company providing enterprise software maintenance and support services. RMNI accounts for 22.68% of the total portfolio value, making it the single most significant holding. The firm holds 23,565,433 shares valued at $100,388,745.
Rimini Street's substantial allocation suggests confidence in its business model and potential for growth despite market skepticism sometimes faced by the company. The Technology sector overall represents 67.23% of Adams Street's portfolio, significantly boosted by this primary holding. Notably, there were no changes reported in the number of shares held for RMNI from the prior period.
The second major position is Corvus Pharmaceuticals Inc (CRVS), operating within the Healthcare sector. This stock allocation stands at 11.06%, valued at $48,937,703 with 3,275,616 shares held. Corvus develops and commercializes medicines for serious diseases affecting the immune system.
Healthcare forms another core part of Adams Street's investment strategy, currently representing 32.77% of the portfolio value. The firm's selection of CRVS indicates an interest in innovative biopharmaceutical companies targeting significant therapeutic areas. Like RMNI, there were no reported changes in shares for Corvus Pharmaceuticals during this period.
Adams Street Partners' current top holdings are RMNI and CRVS. This two-stock portfolio is highly concentrated, reflecting the firm's strategy of backing its top picks with significant capital. The Technology allocation via RMNI dominates at 22.68%, while Healthcare receives substantial weight through Corvus Pharmaceuticals.
Given that there were no reported changes in shares for either holding (change_in_shares_from_prior_period: 0, change_percent_from_prior_period: 0.0%), Adams Street appears to be maintaining its confidence and commitment to these specific companies within the portfolio structure.